Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Serum-free expansion of cells in culture

Inactive Publication Date: 2007-06-07
JW PHARMA CORP
View PDF1 Cites 26 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0016] The invention also relates to a method of maintaining embryonic stem cells in an undifferentiated state, comprising administering to the stem cell an agent, such as IQ-1, that selectively interacts with a differentially spliced regulatory subunit of PR72/130 of the serine/threonine protein phosphatase PP2A, where in the interaction of β-catenin/CBP is increased.
[0017] The invention further relates to a method of maintaining embryonic stem cells in an undifferentiated state, comprising administering to the stem cell an agent that selectively interacts with a differentially spliced regulatory subunit of PR72/130 of the serine/threonine prote

Problems solved by technology

However, the development of such applications for adult stem cells has been severely impaired due to the inability to propagate and expand functional adult stem cells in culture.
To date, this has proven to be a singular challenge in stem cell research (Sherley, J.
The challenge of this undertaking lies in the stem cell's predisposition to differentiate.
This problem may be associated with the inherent asymmetric cell kinetics of stem cells in postnatal somatic tissues (Sherley, J.
However, none of the existing ex vivo methods can prevent differentiation of stem cells while promoting proliferation (Rebel, VI. et al.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Serum-free expansion of cells in culture
  • Serum-free expansion of cells in culture
  • Serum-free expansion of cells in culture

Examples

Experimental program
Comparison scheme
Effect test

example 1

PR72 / 130 and ES Cell Proliferation

[0277] The small molecule IQ-1 (Asahi Kasei Pharma, FIG. 1) selectively increased β-catenin's usage of CBP as a coactivator at the expense of the use of p300, thereby maintaining the embryonic (ES) cells in an undifferentiated state. The combination of Wnt3a and IQ-1 allowed for proliferation and maintenance of pluripotency as judged by the expression of Oct4, Nanog and Rex1, whereas IQ-1 alone was not sufficient to cause proliferation and maintain pluripotency of ES cells.

[0278] The present example relates to the identification of the molecular target of IQ-1. To identify the molecular target of IQ-1, whole cell lysates from P19 embryonic carcinoma cells were treated with biotinylated IQ-1. Compared to a control biotinylated compound (FIG. 3A, lane 2), biotinylated IQ-1 selectively bound three proteins (FIG. 3A, lane 3). The two bands at 72 and 130 kDa were identified by mass spectral sequencing as the differentially spliced regulatory subunits P...

example 2

IQ-1 Maintained the Undifferentiated State of ESCs

[0280] Murine ESCs (D3 ES) were screened with a chemical library (Asahi Kasei) to identify compounds that enhanced Alkaline Phosphatase (AP) production, a marker of undifferentiated ESCs (12). From this screen, IQ-1 (MW=362.42, FIG. 1A) was identified, which dose dependently increased AP activity (FIG. 1B), in media containing 15% FCS without the addition of exogenous leukemia inhibitory factor (LIF). Treatment with IQ-1 resulted in enhanced expression of the undifferentiated ESC marker, Stage Specific Embryonic Antigen 1 (SSEA-1) in a dose dependent fashion (FIG. 1C).

[0281] IQ-1 allowed for long term expansion of ESCs in culture without MEFs and without the addition of exogenous LIF. Mouse D3 ESCs were cultured in media containing 15% FCS plus 4 μg / ml IQ-1 for 65 days. The ESCs continued to proliferate at a steady rate with an approximate 2 log increase every ten days (FIG. 1D).

example 3

IQ-1 Maintained Murine ESC Self-Renewal Independently of LIF

[0282] The cytokine LIF, by activating the Stat3 signal transduction pathway, maintains murine ESC symmetrical self-renewal and blocks differentiation (13, 14, 15). LIF did not maintain human ESC self-renewal (16, 17). Nanog is a divergent homeoprotein pluripotency sustaining factor for ESCs (18, 19). Nanog has been shown to act in parallel with LIF-driven stimulation of Stat3 to drive ESC self-renewal. Additionally, elevated expression of Nanog is sufficient for clonal expansion of ESCs and maintenance of expression of the key stem cell transcription factor Oct4, in the absence of Stat3 activation (19).

[0283] To further investigate the mechanism of action of IQ-1, the effects of IQ-1 on Nanog expression were determined. Whereas feeder-free ESCs treated with LIF only slightly increased Nanog levels, IQ-1 significantly increased and maintained Nanog expression in culture as judged by real time RT-PCR (FIG. 2A). Removal of ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Methods and agents are disclosed for modulating the interaction of β-catenin or γ-catenin with CBP or p300. Agents that increase the binding of CBP to β-catenin are associated with enhancing the β-catenin-related proliferation of adult stem cells, including hematopoietic stem cells, neural stem cells, skin stem cells, and pancreatic stem cells, as well as embryonic stem cells.

Description

CROSS REFERENCE TO RELATED APPLICATIONS [0001] This application claims the benefit of U.S. Provisional Application No. 60 / 740,173, filed Nov. 28, 2005, which is incorporated herein by reference in its entirety.FIELD OF THE INVENTION [0002] The present invention relates to compounds and methods for modulating the interaction between β-catenin or γ-catenin and the coactivator protein CBP, or β-catenin or γ-catenin and the coactivator protein p300, to promote proliferation / dedifferentiation or differentiation of stem / progenitor cells. DESCRIPTION OF THE RELATED ART [0003] Stem cells have received significant interest over the last few years due to their potential, under suitable cellular microenvironments, to differentiate and develop into a wide array of cell and tissue types. Several important biomedical applications would be enabled by the ability to generate sufficient pools of adult stem cells, including cell replacement therapy, gene therapy, and tissue engineering. According to ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): G01N33/567G01N33/53
CPCC12N5/0606C12N2500/99C12N2501/415C12N2501/999C12Q1/42G01N33/5005G01N33/5058G01N33/5061G01N33/507G01N33/5073G01N33/52G01N33/573G01N33/6872G01N2333/916G01N2500/04C12N2500/90A61P43/00C12N5/00C12N5/0607G01N33/50
Inventor KAHN, MICHAEL
Owner JW PHARMA CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com